| Multi-year follow-up of abciximab therapy in three randomized,placebo-controlled trials of percutaneous coronary revascularization^1 |
Topol, E.J.;Lincoff, A.M.;Kereiakes, D.J.;Kleiman, N.S.;Cohen, E.A.;Ferguson, J.J.;Tcheng, J.E.;Sapp, S.;Califf, R.M.; |
The American Journal of Medicine |
2002-07-01 |
查看 |
